![Michael Reusch](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Reusch
Teknisk/Vetenskaplig/F&U Direktör på
GUARD THERAPEUTICS INTERNATIONAL AB
Profil
Michael Reusch is Chief Medical Officer at Guard Therapeutics International AB since 2022.
Formerly, Dr. Reusch was Senior Director-Medical at Astellas Pharma Global Development, Inc. Dr. Reusch earned a doctorate from the University of Duisburg-Essen.
Aktiva positioner av Michael Reusch
| Företag | Position | Start |
|---|---|---|
| GUARD THERAPEUTICS INTERNATIONAL AB | Teknisk/Vetenskaplig/F&U Direktör | 2022-01-01 |
Tidigare kända positioner av Michael Reusch
| Företag | Position | Slut |
|---|---|---|
Astellas Pharma Global Development, Inc.
 Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Teknisk/Vetenskaplig/F&U Direktör | - |
Michael Reuschs utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
2
Första gradens relationer
3
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 3 |
|---|---|
University of Duisburg-Essen
 University of Duisburg-Essen Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Astellas Pharma Global Development, Inc.
Astellas Pharma Global Development, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical products | Health Technology |
Guard Therapeutics International AB
 Guard Therapeutics International AB Pharmaceuticals: MajorHealth Technology Develops medicine for oxidative stress and acute kidney damage | Health Technology |
